scholarly journals The Effect of Discontinuing Treatment With Blosozumab: Follow‐up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density

2015 ◽  
Vol 30 (9) ◽  
pp. 1717-1725 ◽  
Author(s):  
Christopher P Recknor ◽  
Robert R Recker ◽  
Charles T Benson ◽  
Deborah A Robins ◽  
Alan Y Chiang ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Clinical Trial ◽  
Postmenopausal Women ◽  
Randomized Clinical Trial ◽  
Bone Mineral ◽  
Phase 2 ◽  
Mineral Density ◽  
Low Bone Mineral Density

OP0248 Inhibition of Sclerostin with Romosozumab in Postmenopausal Women with Low Bone Mineral Density: Phase 2 Trial Results

2013 ◽  
Vol 72 (Suppl 3) ◽  
pp. A136.2-A137 ◽  
Author(s):  
M. R. McClung ◽  
A. Grauer ◽  
S. Boonen ◽  
J. P. Brown ◽  
A. Diez-Perez ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Phase 2 ◽  
Mineral Density ◽  
Low Bone Mineral Density ◽  
Phase 2 Trial

scholarly journals Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study

2012 ◽  
Vol 27 (11) ◽  
pp. 2251-2258 ◽  
Author(s):  
Bente Langdahl ◽  
Neil Binkley ◽  
Henry Bone ◽  
Nigel Gilchrist ◽  
Heinrich Resch ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Phase 2 ◽  
Mineral Density ◽  
Low Bone Mineral Density ◽  
Phase 2 Study
Sign in / Sign up

Export Citation Format

Share Document